The global serum biomarkers market is expected to grow at a CAGR of 7.5% during the forecast period, from 2021 to 2030. The growth of this market is driven by the increasing incidence of cancer and rising awareness about cancer screening among people. The increasing prevalence of chronic diseases such as diabetes and obesity has also led to an increase in the number of cancer cases globally.
The global serum biomarkers market is segmented on the basis of type, application, and region. On the basis of type, it can be classified into hepatocellular carcinoma serum biomarkers, lung cancer serum biomarkers, pancreatic & biliary tract cancer serum biomarkers, breast cancer serum biomarkers, and glioblastoma serums biomarker. On the basis of application it can be classified into hospitals (academic & research institutes), ambulatory surgical centers (ASC), and others (hospitals). On the basis on region it can be classified into North America (NA), Latin America (LA), Europe (EU), Asia Pacific (APAC) and Middle East & Africa(MEA).
Some Of The Growth Factors Of This Market:
- The rising awareness about the importance of early detection and diagnosis of various diseases has led to an increase in research and development activities for developing novel biomarkers that can be used for early detection or diagnosis purposes. This has also led to an increase in investments by pharmaceutical companies into this segment which will further fuel the growth of this market over the forecast period (2017-2022).
- Increasing government funding on research and development activities related with biomarker discovery is also expected to fuel growth prospects over the forecast period (2017-2022). For instance, in 2016, US government allocated $1 billion towards funding research on cancer biomarkers which will help accelerate progress in this field over time leading up till 2022 when it is estimated that there will be more than 500 million people suffering from cancer globally according to World Health Organization estimates .
Industry Growth Insights published a new data on “Serum Biomarkers Market”. The research report is titled “Serum Biomarkers Market research by Types (Hepatocellular Carcinoma Serum Biomarkers, Lung Cancer Serum Biomarkers, Pancreatic & Biliary Tract Cancer Serum Biomarkers, Breast Cancer Serum Biomarkers, Glioblastoma Serum Biomarkers, Others), By Applications (Hospitals, Academic & Research Institutes, Ambulatory Surgical Centers, Others), By Players/Companies Roche, Pfizer, Novartis, Abbott, BD, Merck, Eli Lilly, Agilent Technologies, Boehringer Ingelheim, AstraZeneca, Bristol-Myers Squibb, Novo Nordisk, Allergan, Gilead”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Serum Biomarkers Market Research Report
By Type
Hepatocellular Carcinoma Serum Biomarkers, Lung Cancer Serum Biomarkers, Pancreatic & Biliary Tract Cancer Serum Biomarkers, Breast Cancer Serum Biomarkers, Glioblastoma Serum Biomarkers, Others
By Application
Hospitals, Academic & Research Institutes, Ambulatory Surgical Centers, Others
By Companies
Roche, Pfizer, Novartis, Abbott, BD, Merck, Eli Lilly, Agilent Technologies, Boehringer Ingelheim, AstraZeneca, Bristol-Myers Squibb, Novo Nordisk, Allergan, Gilead
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
248
Number of Tables & Figures
174
Customization Available
Yes, the report can be customized as per your need.
Global Serum Biomarkers Market Report Segments:
The global Serum Biomarkers market is segmented on the basis of:
Types
Hepatocellular Carcinoma Serum Biomarkers, Lung Cancer Serum Biomarkers, Pancreatic & Biliary Tract Cancer Serum Biomarkers, Breast Cancer Serum Biomarkers, Glioblastoma Serum Biomarkers, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Academic & Research Institutes, Ambulatory Surgical Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche
- Pfizer
- Novartis
- Abbott
- BD
- Merck
- Eli Lilly
- Agilent Technologies
- Boehringer Ingelheim
- AstraZeneca
- Bristol-Myers Squibb
- Novo Nordisk
- Allergan
- Gilead
Highlights of The Serum Biomarkers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Hepatocellular Carcinoma Serum Biomarkers
- Lung Cancer Serum Biomarkers
- Pancreatic & Biliary Tract Cancer Serum Biomarkers
- Breast Cancer Serum Biomarkers
- Glioblastoma Serum Biomarkers
- Others
- By Application:
- Hospitals
- Academic & Research Institutes
- Ambulatory Surgical Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Serum Biomarkers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Serum biomarkers are proteins or other molecules in the blood that can be used to diagnose, monitor, and treat diseases.
Some of the major companies in the serum biomarkers market are Roche, Pfizer, Novartis, Abbott, BD, Merck, Eli Lilly, Agilent Technologies, Boehringer Ingelheim, AstraZeneca, Bristol-Myers Squibb, Novo Nordisk, Allergan, Gilead.
The serum biomarkers market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Serum Biomarkers Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Serum Biomarkers Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Serum Biomarkers Market - Supply Chain
4.5. Global Serum Biomarkers Market Forecast
4.5.1. Serum Biomarkers Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Serum Biomarkers Market Size (000 Units) and Y-o-Y Growth
4.5.3. Serum Biomarkers Market Absolute $ Opportunity
5. Global Serum Biomarkers Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Serum Biomarkers Market Size and Volume Forecast by Type
5.3.1. Hepatocellular Carcinoma Serum Biomarkers
5.3.2. Lung Cancer Serum Biomarkers
5.3.3. Pancreatic & Biliary Tract Cancer Serum Biomarkers
5.3.4. Breast Cancer Serum Biomarkers
5.3.5. Glioblastoma Serum Biomarkers
5.3.6. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Serum Biomarkers Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Serum Biomarkers Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Academic & Research Institutes
6.3.3. Ambulatory Surgical Centers
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Serum Biomarkers Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Serum Biomarkers Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Serum Biomarkers Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Serum Biomarkers Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Serum Biomarkers Demand Share Forecast, 2019-2026
9. North America Serum Biomarkers Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Serum Biomarkers Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Serum Biomarkers Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Academic & Research Institutes
9.4.3. Ambulatory Surgical Centers
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Serum Biomarkers Market Size and Volume Forecast by Type
9.7.1. Hepatocellular Carcinoma Serum Biomarkers
9.7.2. Lung Cancer Serum Biomarkers
9.7.3. Pancreatic & Biliary Tract Cancer Serum Biomarkers
9.7.4. Breast Cancer Serum Biomarkers
9.7.5. Glioblastoma Serum Biomarkers
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Serum Biomarkers Demand Share Forecast, 2019-2026
10. Latin America Serum Biomarkers Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Serum Biomarkers Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Serum Biomarkers Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Academic & Research Institutes
10.4.3. Ambulatory Surgical Centers
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Serum Biomarkers Market Size and Volume Forecast by Type
10.7.1. Hepatocellular Carcinoma Serum Biomarkers
10.7.2. Lung Cancer Serum Biomarkers
10.7.3. Pancreatic & Biliary Tract Cancer Serum Biomarkers
10.7.4. Breast Cancer Serum Biomarkers
10.7.5. Glioblastoma Serum Biomarkers
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Serum Biomarkers Demand Share Forecast, 2019-2026
11. Europe Serum Biomarkers Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Serum Biomarkers Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Serum Biomarkers Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Academic & Research Institutes
11.4.3. Ambulatory Surgical Centers
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Serum Biomarkers Market Size and Volume Forecast by Type
11.7.1. Hepatocellular Carcinoma Serum Biomarkers
11.7.2. Lung Cancer Serum Biomarkers
11.7.3. Pancreatic & Biliary Tract Cancer Serum Biomarkers
11.7.4. Breast Cancer Serum Biomarkers
11.7.5. Glioblastoma Serum Biomarkers
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Serum Biomarkers Demand Share, 2019-2026
12. Asia Pacific Serum Biomarkers Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Serum Biomarkers Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Serum Biomarkers Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Academic & Research Institutes
12.4.3. Ambulatory Surgical Centers
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Serum Biomarkers Market Size and Volume Forecast by Type
12.7.1. Hepatocellular Carcinoma Serum Biomarkers
12.7.2. Lung Cancer Serum Biomarkers
12.7.3. Pancreatic & Biliary Tract Cancer Serum Biomarkers
12.7.4. Breast Cancer Serum Biomarkers
12.7.5. Glioblastoma Serum Biomarkers
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Serum Biomarkers Demand Share, 2019-2026
13. Middle East & Africa Serum Biomarkers Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Serum Biomarkers Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Serum Biomarkers Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Academic & Research Institutes
13.4.3. Ambulatory Surgical Centers
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Serum Biomarkers Market Size and Volume Forecast by Type
13.7.1. Hepatocellular Carcinoma Serum Biomarkers
13.7.2. Lung Cancer Serum Biomarkers
13.7.3. Pancreatic & Biliary Tract Cancer Serum Biomarkers
13.7.4. Breast Cancer Serum Biomarkers
13.7.5. Glioblastoma Serum Biomarkers
13.7.6. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Serum Biomarkers Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Serum Biomarkers Market: Market Share Analysis
14.2. Serum Biomarkers Distributors and Customers
14.3. Serum Biomarkers Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Pfizer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Novartis
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Abbott
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. BD
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Merck
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Eli Lilly
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Agilent Technologies
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Boehringer Ingelheim
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. AstraZeneca
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Bristol-Myers Squibb
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Novo Nordisk
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Allergan
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Gilead
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
